MYRIAD GENETICS INC (MYGN)

US62855J1043 - Common Stock

15.12  -0.18 (-1.18%)

After market: 15.12 0 (0%)

Buy % Consensus

71

ChartMill assigns a Buy % Consensus number of 71% to MYGN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 30.89. This target is 104.31% above the current price.
MYGN was analyzed by 21 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about MYGN.
In the previous month the buy percentage consensus was at a similar level.
MYGN was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 15.1216.1631.6230.8942.00 - 6.88% 109.13% 104.31% 177.78%
Up and Down Grades
Date Firm Action Rating
2024-11-18 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-11-11 Piper Sandler Maintains Neutral -> Neutral
2024-09-19 Morgan Stanley Initiate Equal-Weight
2024-08-27 Wells Fargo Initiate Overweight
2024-08-13 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-08-13 Piper Sandler Maintains Neutral -> Neutral
2024-08-07 TD Cowen Maintains Hold -> Hold
2024-08-07 JP Morgan Maintains Underweight -> Underweight
2024-06-27 ScotiaBank Initiate Sector Outperform
2024-05-13 Piper Sandler Maintains Neutral -> Neutral
2024-05-08 Leerink Partners Upgrade Market Perform -> Outperform
2024-01-30 Goldman Sachs Maintains Buy -> Buy
2024-01-29 Goldman Sachs Maintains Buy -> Buy
2023-12-21 Piper Sandler Initiate Neutral
2023-12-19 Wells Fargo Initiate Equal-Weight
2023-12-14 Guggenheim Initiate Buy
2023-12-13 Wolfe Research Initiate Outperform
2023-11-07 JP Morgan Maintains Underweight -> Underweight
2023-08-07 JP Morgan Maintains Underweight -> Underweight
2023-07-24 Goldman Sachs Maintains Buy -> Buy
2023-07-21 Goldman Sachs Maintains Buy -> Buy
2023-05-24 Goldman Sachs Maintains Buy -> Buy
2023-05-23 Goldman Sachs Upgrade Sell -> Buy
2023-05-04 Stephens & Co. Reiterate Equal-Weight
2023-05-04 Goldman Sachs Maintains Sell
2023-03-06 Stephens & Co. Maintains Equal-Weight
2023-03-03 Raymond James Maintains Outperform
2023-01-18 Raymond James Upgrade Market Perform -> Outperform
2022-11-02 SVB Leerink Maintains Market Perform
2022-10-06 Stephens & Co. Initiate Equal-Weight